Venovenous extracorporeal membrane oxygenation (VV ECMO) has gained popularity for the treatment of refractory respiratory failure during and after the 2009 influenza pandemic, and still represents a precious therapeutic resource for severe novel coronavirus 2019 infection. However, most of the published studies are small case series, and only two randomized trials exist in literature.
Aim:
Aim of this systematic review is to describe trends in VV ECMO treatment outcomes according to large studies only.
Methods:
We searched and included studies with more than 100 VV ECMO cases dated up to August 1st, 2019.
Results:
Thirty-three studies published in the period 2011–2019 met inclusion criteria, for a total of 12,860 patients (age 46.3 ± 17.4 years). ARDS was mainly by pneumonia, in 3126 (37%) cases; further 401(7%) patients had H1N1 Influenza A infection. Cannulation-related complications occurred in 502 (7%) cases. Weighted mean (95% confidence interval) of VV ECMO duration was 8.9 (8.7–9.1) days, and ICU stay was 23.6 (22.4–24.8) days. Mortality at the longest follow up available was 40%. Data collection in 70% of the studies had a duration of >5 years.
Conclusion:
This study reveals the characteristics of large case VV ECMO studies.
PeekGJMugfordMTiruvoipatiR, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet2009; 374: 1351–1363.
2.
CombesAHajageDCapellierG, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med2018; 378: 1965–1975.
3.
BlandJMKerrySM.Weighted comparison of means. BMJ1998; 316: 129.
4.
ArachchillageDRJPassarielloMLaffanM, et al. Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure. Semin Thromb Hemost2018; 44: 276–286.
5.
BonizzoliMLazzeriCCianchiG, et al. Serial lactate measurements as a prognostic tool in venovenous extracorporeal membrane oxygenation support. Ann Thorac Surg2017; 103: 812–818.
6.
BréchotNMastroianniCSchmidtM, et al. Retrieval of severe acute respiratory failure patients on extracorporeal membrane oxygenation: any impact on their outcomes?J Thorac Cardiovasc Surg2018; 155: 1621–1629, e2.
7.
BurrellAJCLubnowMEngerTB, et al. The impact of venovenous extracorporeal membrane oxygenation on cytokine levels in patients with severe acute respiratory distress syndrome: a prospective, observational study. Crit Care Resusc2017; 19: 37–44.
8.
CamboniDPhilippALubnowM, et al. Support time-dependent outcome analysis for veno-venous extracorporeal membrane oxygenation. Eur J Cardiothorac Surg2011; 40: 1341–1346; Discussion 1346–1347.
9.
ChengY-TWuM-YChangY-S, et al. Developing a simple preinterventional score to predict hospital mortality in adult venovenous extracorporeal membrane oxygenation: a pilot study. Medicine (Baltimore)2016; 95: e4380.
10.
ChiuL-CHuH-CHungC-Y, et al. Dynamic driving pressure associated mortality in acute respiratory distress syndrome with extracorporeal membrane oxygenation. Ann Intensive Care2017; 7: 12.
11.
ChoHJHongHKimDW, et al. Viability of mesenchymal stem cells in an ex vivo circulation system. ASAIO J2020; 66(4): 433−440.
12.
CianchiGLazzeriCBonizzoliM, et al. The 8-year experience of the florence referral ECMO center and retrieval team for acute respiratory failure. J Cardiothorac Vasc Anesth2018; 32: 1142–1150.
13.
EngerTBPhilippALubnowM, et al. Long-term survival in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation. Crit Care Med2017; 45: 1718–1725.
14.
Fletcher-SandersjööABartekJThelinEP, et al. Predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: an observational cohort study. J Intensive Care2017; 5: 27.
15.
HaneyaADiezCPhilippA, et al. Impact of acute kidney injury on outcome in patients with severe acute respiratory failure receiving extracorporeal membrane oxygenation. Crit Care Med2015; 43: 1898–1906.
16.
HsinC-HWuM-YHuangC-C, et al. Venovenous extracorporeal membrane oxygenation in adult respiratory failure: scores for mortality prediction. Medicine (Baltimore)2016; 95: e3989.
17.
JenqC-CTsaiF-CTsaiT-Y, et al. Effect of anemia on prognosis in patients on extracorporeal membrane oxygenation. Artif Organs2018; 42: 705–713.
18.
KanjiHDChouldechovaAHarveyC, et al. Safety and outcomes of mobile ECMO using a bicaval dual-stage venous catheter. ASAIO J2017; 63: 351–355.
19.
KonZNBittleGJPasrijaC, et al. Venovenous versus venoarterial extracorporeal membrane oxygenation for adult patients with acute respiratory distress syndrome requiring precannulation hemodynamic support: a review of the ELSO registry. Ann Thorac Surg2017; 104: 645–649.
20.
KutlešaMBaršićB.Development of the first adult respiratory extracorporeal membrane oxygenation center in Croatia under emergency circumstances. Int J Artif Organs2017; 39: 558–562.
21.
LehleKPhilippAZemanF, et al. Technical-induced hemolysis in patients with respiratory failure supported with veno-venous ECMO - Prevalence and risk factors. PLoS ONE2015; 10: e0143527.
22.
LockieCJAGillonSABarrettNA, et al. Severe respiratory failure, extracorporeal membrane oxygenation, and intracranial hemorrhage. Crit Care Med2017; 45: 1642–1649.
23.
LorussoRGelsominoSPariseO, et al. Neurologic injury in adults supported with veno-venous extracorporeal membrane oxygenation for respiratory failure: findings from the extracorporeal life support organization database. Crit Care Med2017; 45: 1389–1397.
24.
MazzeffiMKonZMenakerJ, et al. Large dual-lumen extracorporeal membrane oxygenation cannulas are associated with more intracranial hemorrhage. ASAIO J2019; 65: 674–677.
25.
PoslusznyJRycusPTBartlettRH, et al. Outcome of adult respiratory failure patients receiving prolonged (⩾14 days) ECMO. Ann Surg2016; 263: 573–581.
26.
RiedMSommerauerLLubnowM, et al. Thoracic bleeding complications in patients with venovenous extracorporeal membrane oxygenation. Ann Thorac Surg2018; 106: 1668–1674.
27.
Rodriguez-GoncerIThomasSFodenP, et al. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation. Eur J Clin Microbiol Infect Dis2018; 37: 1251–1257.
28.
SalnaMChicotkaSBiscottiM, et al. Management of surge in extracorporeal membrane oxygenation transport. Ann Thorac Surg2018; 105: 528–534.
29.
SchmidtMSchellongowskiPPatronitiN, et al. Six-month outcome of immunocompromised severe ARDS patients rescued by ECMO. An international multicenter retrospective study. Am J Respir Crit Care Med. Epub ahead of print 2018. https://doi.org/10.1164/rccm.201708-1761OC.
30.
SchmidtMPhamTArcadipaneA, et al. Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort. Am J Respir Crit Care Med2019; 200: 1002–1012.
31.
StaudacherDLBodeCWengenmayerT.Duration of extracorporeal membrane oxygenation is a poor predictor of hospital survival. J Crit Care2016; 32: 207–208.
32.
ThomasGHraiechSCassirN, et al. Venovenous extracorporeal membrane oxygenation devices-related colonisations and infections. Ann Intensive Care2017; 7: 111.
33.
WuM-YHuangC-CWuT-I, et al. Is there a preinterventional mechanical ventilation time limit for candidates of adult respiratory extracorporeal membrane oxygenation. ASAIO J2017; 63: 650–658.
34.
YeoHJKimDJeonD, et al. Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the extracorporeal life support organization registry. Crit Care2017; 21: 297.
35.
YeoHJChoWHKimD.Learning curve for multidisciplinary team setup in veno-venous extracorporeal membrane oxygenation for acute respiratory failure. Perfusion2019; 34: 30–38.
36.
GarlandAOlafsonKRamseyCD, et al. Epidemiology of critically ill patients in intensive care units: a population-based observational study. Crit Care2013; 17: R212.
37.
GoligherECTomlinsonGHajageD, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA2018; 320: 2251–2259.
38.
MunshiLWalkeyAGoligherE, et al. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med2019; 7: 163–172.
39.
PappalardoFPieriMGrecoT, et al. Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score. Intensive Care Med2013; 39: 275–281.
40.
BartlettRHOginoMTBrodieD, et al. Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J2020; 66(5): 472−474.
41.
ZangrilloABerettaLScandroglioAM, et al. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc2020; 22(3): 200–211.
42.
PatronitiNZangrilloAPappalardoF, et al. The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks. Intensive Care Med2011; 37: 1447–1457.
43.
AustinDEBurnsBLoweD, et al. Retrieval of critically ill adults using extracorporeal membrane oxygenation: the nine-year experience in New South Wales. Anaesth Intensive Care2018; 46: 579–588.
44.
ForrestPRatchfordJBurnsB, et al. Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience. Intensive Care Med2011; 37: 824–830.
45.
GarciaBCousinNBourelC, et al. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome. Crit Care2020; 24: 428.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
